JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Intuitive Surgical Inc

Chiusa

SettoreSettore sanitario

471.65 0.36

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

469.77

Massimo

475.46

Metriche Chiave

By Trading Economics

Entrata

-45M

658M

Vendite

187M

2.4B

P/E

Media del settore

67.603

34.393

EPS

1.81

Margine di Profitto

26.984

Dipendenti

15,638

EBITDA

268M

987M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+28.25% upside

Dividendi

By Dow Jones

Utili prossimi

16 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-12B

173B

Apertura precedente

471.29

Chiusura precedente

471.65

Notizie sul Sentiment di mercato

By Acuity

10%

90%

5 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bearish Evidence

Intuitive Surgical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 lug 2025, 21:13 UTC

Utili

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 apr 2025, 20:55 UTC

Utili

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 gen 2025, 21:41 UTC

Utili

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 gen 2025, 18:37 UTC

Acquisizioni, Fusioni, Takeovers

Intuitive to Establish Direct Presence in Europe With Acquisition

22 lug 2025, 20:14 UTC

Utili

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 lug 2025, 20:13 UTC

Utili

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 lug 2025, 20:13 UTC

Utili

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Net $658.4M >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 apr 2025, 20:13 UTC

Utili

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Net $698.4M >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 gen 2025, 21:17 UTC

Utili

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 gen 2025, 18:18 UTC

Utili

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 gen 2025, 13:11 UTC

Notizie principali

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 gen 2025, 09:51 UTC

Azioni calde

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 gen 2025, 21:10 UTC

Utili

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 gen 2025, 21:09 UTC

Utili

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 gen 2025, 21:09 UTC

Utili

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Net $685.7M >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q EPS $1.88 >ISRG

Confronto tra pari

Modifica del prezzo

Intuitive Surgical Inc Previsione

Obiettivo di Prezzo

By TipRanks

28.25% in crescita

Previsioni per 12 mesi

Media 602.89 USD  28.25%

Alto 685 USD

Basso 440 USD

Basato su 22 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Intuitive Surgical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

22 ratings

17

Acquista

4

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

514.59 / 539.05Supporto e resistenza

A breve termine

Weak Bearish Evidence

A termine intermedio

Weak Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

5 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.